Literature DB >> 468973

Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty.

J Imperato-McGinley, R E Peterson, R Stoller, W E Goodwin.   

Abstract

A 31-yr-old male pseudohermaphrodite is reported with 17 beta-hydroxysteroid dehydrogenase deficiency. Laboratory data revealed a plasma testosterone of 228 ng/100 ml, a plasma androstenedione of 620 ng/100 ml, and an abnormal androstenedione to testosterone ratio. Plasma estradiol was 4.6 ng/100 ml and plasma estrone was 22 ng/100 ml. This subject was born in a hospital, incontrovertibly declared to be a female, and unambiguously raised as a girl by his parents for the first 17 yr of his life. At age 14 yr, he was able to change to a male gender role with ease. As an adult, he is a well adjusted, happily married man with a successful professional career. Surgical correction of bilateral cryptorchidism and hypospadias was carried out at age 14 yr. At age 30 yr, he developed a teratocarcinoma-seminoma of the right testis with retroperitoneal node metastases. After orchiectomy and retroperitoneal node dissection, he was placed on chemotherapy and is presently free of metastases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468973     DOI: 10.1210/jcem-49-3-391

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Steroid enzyme defects leading to male pseudohermaphroditism.

Authors:  M G Forest
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

2.  Robert Jesse Stoller 1924-1991.

Authors:  R Green
Journal:  Arch Sex Behav       Date:  1992-08

Review 3.  Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  Lisal J Folsom; Mariam Hjaige; Jiayan Liu; Erica A Eugster; Richard J Auchus
Journal:  Mol Cell Endocrinol       Date:  2018-11-30       Impact factor: 4.102

4.  Male pseudohermaphroditism due to 5 alpha-reductase-2 deficiency in an Arab kindred.

Authors:  H M al-Attia
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

Review 5.  Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  M F Faienza; L Giordani; M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

Review 6.  Gender verification in competitive sports.

Authors:  J L Simpson; A Ljungqvist; A de la Chapelle; M A Ferguson-Smith; M Genel; A S Carlson; A A Ehrhardt; E Ferris
Journal:  Sports Med       Date:  1993-11       Impact factor: 11.136

7.  Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency.

Authors:  A Farkas; A Rosler
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

8.  Prepubertal male pseudohermaphroditism due to 17-ketosteroid reductase deficiency: diagnostic value of a hCG test and lack of HLA association.

Authors:  I J Arnhold; B B Mendonça; J A Diaz; C Nogueira; M C Batista; G Madureira; D Oliveira; W Nicolau; W Bloise
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

9.  Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy?

Authors:  Janet Chuang; Amy Vallerie; Lesley Breech; Howard M Saal; Shumyle Alam; Peggy Crawford; Meilan M Rutter
Journal:  Int J Pediatr Endocrinol       Date:  2013-09-12

10.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.